Shanghai-headquartered biotech startup InventisBio has raised $19 million in its Series B round of funding led by Orbimed Asia Partners, a healthcare-focused investment firm, the company said in a release.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
